These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7060216)

  • 21. Testing of some benzidine analogues for microsomal activation to bacterial mutagens.
    Garner RC
    Cancer Lett; 1975 Sep; 1(1):39-42. PubMed ID: 797441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM
    Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroperoxidase I catalyzes peroxidative activation of 3,3'-dichlorobenzidine to a mutagen in Salmonella typhimurium.
    McGowan-Jordan IJ; Josephy PD
    Arch Biochem Biophys; 1990 Nov; 282(2):352-7. PubMed ID: 2241156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo binding of 3,3'-dichlorobenzidine to rat and mouse tissue DNA.
    Ghosal A; Iba MM
    Cancer Lett; 1990 Sep; 53(2-3):197-204. PubMed ID: 2208080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of the conjugation of lipid dienes in hepatic microsomes by 3,3'-dichlorobenzidine.
    Iba MM; Lang B
    Biochem Pharmacol; 1988 Mar; 37(5):781-91. PubMed ID: 3345196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogen-DNA adduct formation as a predictor of metabolic activation pathways and reactive intermediates in benzidine carcinogenesis.
    Kadlubar FF; Yamazoe Y; Lang NP; Chu DZ; Beland FA
    Adv Exp Med Biol; 1986; 197():537-49. PubMed ID: 3766280
    [No Abstract]   [Full Text] [Related]  

  • 27. Lack of bioavailability of dichlorobenzidine form diarylide azo pigments: molecular dosimetry for hemoglobin and DNA adducts.
    Sagelsdorff P; Haenggi R; Heuberger B; Joppich-Kuhn R; Jung R; Weideli HJ; Joppich M
    Carcinogenesis; 1996 Mar; 17(3):507-14. PubMed ID: 8631137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laser Irradiation of Organic Tattoo Pigments Releases Carcinogens with 3,3'-Dichlorobenzidine Inducing DNA Strand Breaks in Human Skin Cells.
    Hering H; Sung AY; Röder N; Hutzler C; Berlien HP; Laux P; Luch A; Schreiver I
    J Invest Dermatol; 2018 Dec; 138(12):2687-2690. PubMed ID: 29935208
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigation of possible metabolism of pigment yellow 17, a 3,3'-dichlorobenzidine-based pigment, after inhalation exposure in rats.
    Hofmann T; Schmidt D
    Arch Toxicol; 1993; 67(2):141-4. PubMed ID: 8481102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of dichlorobenzidine in the urine of rats, rabbits and monkeys treated with C.I. pigment yellow 13.
    Mondino A; Achari R; Dubini M; Marchisio MA; Silvestri S; Zanolo G
    Med Lav; 1978; 69(6):693-7. PubMed ID: 109745
    [No Abstract]   [Full Text] [Related]  

  • 31. Possible carcinogenic metabolites of azo dye and pigment: trace-level determination of benzidine, 3,3'-dichlorobenzidine and their acetylated and conjugated products in human and hamster urine.
    Bowman MC; Nony CR
    IARC Sci Publ; 1981; (40):193-217. PubMed ID: 7327672
    [No Abstract]   [Full Text] [Related]  

  • 32. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver and urinary bladder tumors in dogs from 3,3'-dichlorobenzidine.
    Stula EF; Barnes JR; Sherman H; Reinhardt CF; Zapp JA
    J Environ Pathol Toxicol; 1978; 1(4):475-90. PubMed ID: 722199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acute 3,3'-dichlorobenzidine administration on rat hepatic enzymic and nonenzymic microsomal lipid peroxidation and antioxidant status.
    Iba MM
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):243-52. PubMed ID: 3602587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomonitoring of aromatic amines. IV: Use of hemoglobin adducts to demonstrate the bioavailability of cleavage products from diarylide azo pigments in vivo.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1994; 68(1):8-14. PubMed ID: 8166610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The binding of dimethylnitrosamine to nucleic acids catalyzed by liver enzymic fractions.
    Grilli S; Bragaglia R; Prodi G
    Cancer Lett; 1975 Nov; 1(2):85-90. PubMed ID: 1235064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sorption of benzidine and 3,3'-dichlorobenzidine to lake sediments. 1. Conceptualization and development of a multiparameter model.
    Donaldson FP; Nyman MC
    Environ Toxicol Chem; 2005 May; 24(5):1022-8. PubMed ID: 16110977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of hemoglobin adducts formed in rats exposed orally with 3,3'-dichlorobenzidine by GC/MS-SIM.
    Lee JH; Shin HS
    Toxicol Ind Health; 2002 May; 18(4):191-9. PubMed ID: 12974542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,3'-dichlorobenzidine.
    Hopmeier AP
    J Anal Toxicol; 1989; 13(1):64. PubMed ID: 2709829
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine.
    Frederick CB; Weis CC; Flammang TJ; Martin CN; Kadlubar FF
    Carcinogenesis; 1985 Jul; 6(7):959-65. PubMed ID: 4017176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.